South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the development of active pharmaceutical ingredients (APIs).JW Pharmaceutical said on Monday that it has signed an agreement with Merck Life Science to resea
JVM's Vizen EX Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug dispensing automation machines in the US, on Jan. 2 to sell a fully automated drug inspection machine from its subsidiary JVM. A
Syntekabio,Inc., a South Korean artificial intelligence (AI) drug development company, said on Monday it has launched its cloud-based AI drug development platform STB Cloud in the US market.STB Cloud is the first cloud-based AI drug development service. Syntekabio's AI new-drug development pla